drugset / Trial / NCT01304095

Ranolazine, Ethnicity and the Metabolic Syndrome

NCT01304095

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to measure the effect of ranolazine on ETT (exercise treadmill test) exercise duration in four ethnic subgroups with established coronary artery disease and risk factor(s) for the metabolic syndrome: Caucasian, African American, Southeast Asian and East Indian.

Timeline

Start
2011-01
Primary completion
2013-07
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranolazine Small molecule 1 g Oral